Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

AMD’s AI-Powered Stock Price Rally Just Shifted Gears

Advanced Micro Devices' long-awaited AI stock price rally is underway following a new deal announcement and an increase to the buyback.

5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears

5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears

Insiders are buying these small-cap stocks, but not the ones you think. Major shareholders, including activist investors, are increasing their stakes.

Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case

Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case

Verizon demonstrates financial growth and remains an appealing dividend stock, reinforced by favorable analyst reports indicating a solid investment prospect.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

D-Wave Pushes Back on Short Seller Case With Strong Earnings

D-Wave Quantum's latest earnings report shows remarkable gains to revenue, gross margin, and cash position, fueling an optimistic view of the company's future.

Oklo Reaches Critical Mass, Atomic Upside Still Available

Oklo is advancing its Aurora project and remains on track for a late 2027 or early 2028 deployment and commercial operations.

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.

Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore

These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next

inkl

Read news from The Economist, FT, and more,
with one subscription

AppLovin Surges on Earnings: What's Next for This Tech Standout?

AppLovin Surges on Earnings: What's Next for This Tech Standout?

AppLovin answered the call again in Q1. Its e-commerce push continues to show promising results, a growth catalyst that could help push shares higher.

U.S. Regulators Target CrowdStrike: Is It a Signal or Noise?

U.S. Regulators Target CrowdStrike: Is It a Signal or Noise?

CrowdStrike faces a regulatory probe involving a $32 million transaction with Carahsoft, which could create more volatility in CRWD stock before earnings

3 AI ETFs Tapping Into the Heart of the AI Revolution

3 AI ETFs Tapping Into the Heart of the AI Revolution

As the AI trade makes a comeback, these three ETFs provide niche opportunities for investors looking to capitalize on the continued growth in AI

Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue Launch

Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue Launch

Archer Aviation's Q1 2025 earnings beat expectations, showcasing financial health and confirming imminent revenue generation from its UAE Launch Edition.

Joby Just Flew Two Aircraft at Once—Here’s Why It Matters

Joby Just Flew Two Aircraft at Once—Here’s Why It Matters

Joby Aviation's simultaneous dual aircraft flights signal accelerating operational capabilities and test program maturity vital for FAA certification.

4 Recent Earnings Winners Riding Fresh Momentum in May

4 Recent Earnings Winners Riding Fresh Momentum in May

Four companies experienced significant short-term rallies following better-than-expected earnings; can they maintain momentum going forward?

Carnival's Comeback: Is the Stock Set for a Profitable Journey?

Carnival's Comeback: Is the Stock Set for a Profitable Journey?

Carnival's strong booking momentum and strategic debt management initiatives signal a positive trajectory for the cruise line in a recovering travel market.

Get all your
news in one place.

100’s of premium titles.
One news app.

Tesla: Get Ready To See It Trading Above $400 Again

Tesla rallies 40% post-earnings as Piper Sandler sets a bullish $400 target, betting big on autonomy and software-led margin expansion.

ON Holding Surges, Leads High-End Retailers Into Reversal

ON Holdings' robust results have it in a stock price reversal and leading other high-end retailers to fresh highs; momentum is rising in Q2.

NVIDIA Stock Surges on Bullish News: How High Could It Climb?

NVIDIA's stock price rebound was supercharged by news it would supply AI infrastructure to Saudi Arabia, a deal worth billions in revenue.

Why Boeing May Be Ready to Take Off After Latest Developments

China has just resumed its new orders for Boeing planes as trade tariffs take on a 90-day pause with the United States, creating upside for the stock.

Get all your
news in one place.

100’s of premium titles.
One news app.

eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?

eBay is outperforming the market in 2025, up nearly 12% year-to-date, and is just 3% below a key breakout level that could spark a move to fresh all-time highs.

Goldman Sachs Warns of 20% Market Sell-Off: Are They Right?

Goldman Sachs strategists are calling for as much as a 20% decline in the S&P 500 index from where it trades today, and there are some signs to back this view.

NuScale Power in Rebound Mode With Short-Squeeze a Possibility

NuScale Technology is positioned to receive its first orders by year's end and to make first deployments by 2030; the stock is set up for a short-squeeze.

Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for Long

With a P/E of just 15 and a ton of bullish analyst support, Qualcomm may just be the best-kept secret in the chip space.

3 Huge S&P 500 Winners From Trump Trade Deal & The Biggest Loser

Trump's trade deal with China lifted many stocks massively, but it also hurt others. Check out the biggest risers and fallers after the breakthrough news.

Why SoundHound’s Growth and Zero Debt Are a Bullish Signal

Soundhound is accelerating hypergrowth in 2025 and is on track to reach profits within two to three years, setting its stock up to rebound.

Best Biotech Stocks to Buy in 2025

Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum.

1 … 26 27 28 29

People

126,719 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play